Price & volume screen · refreshed after the Nov 12, 2026 close
Unusual volume: Healthcare
Stocks that traded far more shares than usual in the latest session. Relative volume compares the latest session with the 20-session average. Volume several times normal often accompanies news, earnings or index changes — a prompt to check what happened.
| # | Company | Price | Today | Volume | Rel. volume | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | ENGNenGene TherapeuticsHealthcare | $2.28 | +26.67% | 11.9M | 12.0× | $152.8M |
| 2 | ECORelectroCoreHealthcare | $5.29 | −31.39% | 619.6K | 5.6× | $48.8M |
| 3 | KROSKeros TherapeuticsHealthcare | $10.08 | +5.66% | 630.1K | 3.9× | $197.8M |
| 4 | MANEVeradermics, IncorporatedHealthcare | $135.29 | −13.59% | 2.3M | 3.6× | $5.71B |
| 5 | SABSSAB BiotherapeuticsHealthcare | $3.08 | −0.96% | 2.1M | 3.4× | $277.5M |
| 6 | CARLCarlsmedHealthcare | $17.30 | −6.99% | 384.8K | 3.3× | $474.1M |
| 7 | EYENational Vision HoldingsHealthcare | $18.57 | +2.65% | 6.5M | 3.2× | $1.45B |
| 8 | XFORX4 PharmaceuticalsHealthcare | $3.17 | −1.86% | 2.2M | 3.2× | $323.7M |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.